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httcense.Abstract Aim of the work: The present study aimed at evaluating the prevalence of subclinical
atherosclerosis and cardiovascular disease by means of assessment of carotid intima media thick-
ness and endothelium dependent function through assessment of brachial artery ﬂow mediated
dilatation in patients with rheumatoid arthritis.
Materials and methods: Twenty six patients with rheumatoid arthritis and 20 healthy control
subjects underwent measurement of brachial artery FMD and CIMT using B-mode gray scale
US for evaluating cardiovascular risk.
Results: The brachial artery FMD was –96.6–6.6% in rheumatoid arthritis (indicating ED), and
20–25% in the control group. The CIMT was 0.50–0.72 mm in rheumatoid arthritis and
0.35–0.47 mm in the control group.
Conclusion: The results from the present study support the use of carotid US and endothelial func-
tion assessment by means of FMD as a useful tool to predict the increased risk of cardiovascularCVD, cardiovascular disease;
nitric oxide; CIMT, carotid
l dysfunction.
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Table 1 The brachial artery diamet
group.
Number D1 (mm) D
5 2.5 3
7 3 3
8 3.2 4
Fig. 1a T
238 N.M. AbdelMaboud, H.H. Elsaiddisease in patients with rheumatoid arthritis. We suggest that the carotid artery US should be per-
formed for all patients with rheumatoid arthritis to establish the risk of cardiovascular complication
which requires more aggressive therapy.
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Rheumatoid arthritis (RA) is the most common systemic auto-
immune disease. Patients with rheumatoid arthritis are at in-
creased risk for cardiovascular diseases (CVD), one of the
earliest manifestations of CVD is endothelial dysfunction(ED)
(1). The endothelium is the innermost lining of the vasculature
and is responsible for maintaining vascular homeostasis via the
balanced production of a number of vasoactive factors such as
nitric oxide (NO) which play an important role in vasodilata-
tion and inhibiting the atherosclerotic process (2). Damage to
the endothelium can reduce (NO) activity, causing endothelial
dysfunction which is an early indicator of CVD (3). ED is an
important sign of early atherosclerosis and can be assessed
non invasively by the impairment of endothelial dependant
ﬂow mediated vasodilatation (ED-FMD) of peripheral arteries
measured by US (4). Increased carotid intima –media thickness
(CIMT), measured by US, is also regarded as an early indica-
tor of atherosclerosis and future CVD (5).
2. Patients and methods
2.1. Patients and control
The subjects in the present study were 26 RA patients (23 fe-
males and 3 males), and 20 healthy control subjects.
All patients have the following criteria: ages between 35 and
60 years, non tobacco users, did not present other autoimmune
diseases, hypertension, diabetes mellitus, dyslipidemia, renaler and FMD in the control
2 (mm) FMD (%)
20
.7 23.3
25
he basal diameter of the brachiainsufﬁciency or received drugs affecting the cardiovascular
system.
20 healthy volunteers were recruited as control .Written
consent was taken from all patients and the control group
and the institutional ethics committee approved the study
protocol.
2.2. Methods: Radiological assessment by US
2.2.1. Carotid US
The subject was made to lie supine with slight hyperextension
of the neck .Both common carotid arteries were examined
using a 7 MHz linear array transducer in a PHILIPS HD11
instrument. Carotid intima –media thickness and lumen diam-
eter were measured from end diastolic M-mode images (mini-
mum distension) of the wall of the distal common carotid
artery in a location not containing plaque. The greater distance
between lumen – intima and media-adventitia interface was
measured. The mean value of the two sides was taken.
2.3. Flow mediated vasodilatation of brachial artery
The procedure was performed on the same US machine and
the same transducer as used in carotid US.
The subject lies in a supine position; the right brachial ar-
tery was scanned in longitudinal section 2–15 cm. above the
antecubital fossa with B-mode. The clearest picture of the ar-
tery at the center was obtained (the transducer was kept con-
stant throughout the procedure by noting the relation of the
artery with the adjacent anatomical landmarks).The luminal
diameter of the artery was measured by calculating the dis-
tance between the proximal and distal intima. Ischemia was in-
duced with a sphygmomanometer cuff placed around the
forearm distal to the scanned region inﬂated to 200 mmHG
for 4 min and then released. A second scan was taken at this
stage and the luminal diameter was measured 60 s. after cuff
deﬂation .The endothelium dependant function is deﬁned by
the formula: D2-D1/D1x100 the higher the numeric value of
the study , the better the endothelial function. ED is considered
when the FMD is <4.55l artery in a normal subject = 3.2 mm.
Fig. 1b The post- occlusion diameter of brachial artery in the same person = 4 mm, FMD 25% denoting good endothelial function.
Fig. 1c The carotid intima media thickness 0.44 mm.
Table 2 The brachial artery diameter and FMD in the
rheumatoid arthritis patients.
Number D1 (mm) D2 (mm) FMD (%)
10 4.3 4.3 0
8 4.1 4.3 4.8
3 3 3.2 6.6
5 3 3.4 96.6
Fig. 2a The basal diameter of the brachial artery i
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This study included 26 patients of rheumatoid arthritis with an
age range of 35–60 years and 20 healthy control subjects with
the same age range.
Table 1 shows the characteristics of the study group in
which the diameter of the brachial artery before the induction
of ischemia (D1) was 2.5 mm in ﬁve subjects, after the release
of ischemia (D2) 3 mm, the FMD was 20%.D1was 3 mm in se-
ven subjects, D2 was 3.7 mm and FMD was 23.3%.D1 was 3.2
in eight subjects, D2 was 4 mm and the FMD was 25% Fig. 1a
and b.
Table 2 shows the characteristics of the rheumatoid arthri-
tis group in which the diameter of the brachial artery before
the induction of ischemia (D1) was 4.3 mm in 10 subjects, after
the release of ischemia (D2) 4.3 mm, the FMD was 0% D1 was
4.1 mm in eight subjects, D2 was 4.3 mm and FMD was 4.8%.
D1 was 3 in three subjects, D2 was 3.2 mm and the FMD was
6.6%. D1 was 3 in ﬁve subjects, D2 was 3.4 mm and the FMD
was –96.6% Figs. 2a and b, 3a and b, 4a and b.
So, the higher the numeric value of the FMD, the better the
endothelial function.
The CIMT in the control group was 0.44 mm in eight per-
sons, 0.47 mm in nine persons, and 0.35 mm in three persons
Fig. 1c Table 3.
The CIMT in the rheumatoid arthritis patients was
0.50 mm in 10 persons, 0.54 mm in nine persons, and
0.56 mm in seven persons Figs. 2c, 3c and 4c Table 4.n a patient with rheumatoid arthritis = 4.3 mm.
Fig. 2b The post- occlusion diameter of brachial artery in the same person = 4.3 mm, FMD 0% denoting poor endothelial function.
Fig. 2c The carotid intima media thickness in the same person
0.72 mm.
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Rheumatoid arthritis is associated with excessive cardiovascu-
lar mortality [6]. Almost half of all deaths in rheumatoid
arthritis results from cardiovascular causes (7). Therefore, it
may be suggested that the main cause of mortality and morbid-
ity is ischemic heart disease in patients with RA (7). DiscoveryFig. 3a The basal diameter of brachial artery inof early interventions in RA disease that might inﬂuence ath-
erosclerotic progression are essentials to determine approaches
that could in turn reduce the subsequent risk of cardiovascular
mortality (8,9). CIMT is a known strong predictor of cardio-
vascular events in the general population (10), and has been
predominantly reported in the literature on patients with RA
(11). The results from our study show that the CIMT has a
high predictive value for the development of CVD. Our results
were the same as Gonzalez–Juanatey C et al. (12) in which the
presence of subclinical atherosclerosis, manifested by increased
value of CIMT is consistent with the high rate of silent ische-
mic heart diseases and sudden cardiac death observed in RA
patients. Van Sijl AM et al (13) proved in their study that
CIMT is frequently used to identify the population at elevated
cardiovascular risk. (17) The results of our study implicate that
the mean CIMT of the common carotid artery was signiﬁ-
cantly higher in RA patients than in healthy subjects. Van Sijl
AM etal (13), found that the CIMT difference between RA pa-
tients and the control subject may be very small as inHiggins
JP et al. (14) and other studies such as Kumeda Y et al. (15)
& Mahajan V et al. (16) found a greater difference. Finally,
Van Sijl AM etal (13) stated that the variation in ultrasound
protocols for determining CIMT between all studies is an
important observation but also complicates the interpretation
of the individual study results. Still, they think that the differ-
ences in ultrasound protocols or in other methodological as-
pects are unlikely to have caused a systematic bias toward
under - or overestimation of CIMT difference between RA pa-
tients and control. So, US scanning of CIMT has been shown
to be an accurate method for estimating cardiovascular riska patient with rheumatoid arthritis = 4.1 mm.
Fig. 3b The post- occlusion diameter of brachial artery in the same person = 4.3 mm, FMD 4.8% denoting poor endothelial function.
Fig. 3c The carotid intima media thickness in the same person
0.64 mm.
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rosis, the mechanisms involved are not clear, but may include
endothelial dysfunction mediated by systemic inﬂammation
(18). Our study demonstrates that patients with RA can also
present endothelial dysfunction which may be the earliest eventFig. 4a The basal diameter of brachial artery inin the atheromatous lesion, so its evaluation is a promising
tool for the estimation of coronary affection. Castro PT
et al. (19) study mentioned that FMD allows an adequate eval-
uation of endothelial behavior and reﬂects the coronary endo-
thelial function and behavior inspite of that the ideal method
for diagnosing endothelial dysfunction has not been estab-
lished yet. Our study coincides with those of Schroeder S
et al. (20) in which the age of the patient does not affect the
endothelial function evaluation with FMD. We have found
no signiﬁcant difference in the different age groups of patients
and the control group regarding the FMD .Like the present
study, other studies like Hurlimann D et al. (21) have found
a signiﬁcant endothelial dysfunction in patients with autoim-
mune disease like RA by means of FMD .The presence of sys-
temic inﬂammation predisposes to atherosclerosis, affecting
the endothelial function and decreasing the production of ni-
tric oxide by the endothelium, this decrease in the nitric oxide
production leads to a smaller arterial dilatation upon induced
ischemia. Quyyumi AA (22) afﬁrms that systemic inﬂamma-
tion markers like FMD, CIMT and pulse wave analysis arise
as a method for evaluating the atherosclerosis risk .He recom-
mends the inclusion of these methods in randomized study for
screening and diagnosis of cardiovascular risk. Considering
that a high level of systemic inﬂammation affects the endothe-
lial function, inﬂammation markers like FMD may provide a
better evaluation for the cardiovascular risk in patients with
RA (23). In our study, we demonstrate that the FMD anda patient with rheumatoid arthritis = 3 mm.
Fig. 4b The post-occlusion diameter of brachial artery in the same person = 3.2 mm, FMD 6.6% denoting poor endothelial function.
Table 3 CIMT in the control group.
Number CIMT (mm)
8 0.44
9 0.47
3 0.35
Table 4 CIMT in the rheumatoid arthritis patients.
Number CIMT (mm)
10 0.50
9 0.54
7 0.56
Fig. 4c The carotid intima media thickness in the same person
0.50 mm.
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are very helpful for the prevention of vascular risk.5. Conclusion
The results from the present study support the use of carotid
US and endothelial function assessment by means of FMD
as a useful tool to predict the increased risk of cardiovasculr
disease in patient with rheumatoid arthritis. We suggest that
the carotid artery US should be performed for all patients with
rheumatoid arthritis to establish the risk of cardiovascular
complication which requires more aggressive therapy.
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